Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN5630572 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Duffy Blood Group, Chemokine Receptor (DARC) (N-Term), (both Isoforms) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Goat
- Epitope
- N-Term, both Isoforms
- Vial size
- 0.025 mg
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1)/Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele.
Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Expression of DARC, CXCR3 and CCR5 in giant cell arteritis.
Davis MB, Walens A, Hire R, Mumin K, Brown AM, Ford D, Howerth EW, Monteil M
PloS one 2015;10(10):e0140098
PloS one 2015;10(10):e0140098
Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD, Wang X, Yang C, Zeng XH, Shao ZM
Oncotarget 2015 Sep 22;6(28):26519-27
Oncotarget 2015 Sep 22;6(28):26519-27
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM
Medical oncology (Northwood, London, England) 2014 Sep;31(9):145
Medical oncology (Northwood, London, England) 2014 Sep;31(9):145
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM
Breast cancer research and treatment 2011 Feb;125(3):715-27
Breast cancer research and treatment 2011 Feb;125(3):715-27
Expression of DARC, CXCR3 and CCR5 in giant cell arteritis.
Brühl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S
Rheumatology (Oxford, England) 2005 Mar;44(3):309-13
Rheumatology (Oxford, England) 2005 Mar;44(3):309-13
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
